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Sphingolipids have been appreciated as bioactive lipids that
regulate a diverse range of cellular responses [1, 2]. In recent
years many efforts of researchers were made to improve our
knowledge of sphingolipids in pathophysiological inflamma-
tion. Different studies demonstrated that cellular signaling in
inflammatory processes is controlled by ceramide [3], sphin-
gosine-1-phosphate (S1P) [4], ceramide-1-phosphate [5], and
glycosphingolipids (such as lactosylceramide and GM3) [6].
The molecular mechanisms underlying this signaling have
been extensively studied.
This special issue is composed of ten articles including
three research articles and seven review articles. These con-
tributions review important discoveries and provide novel
findings that support the multifaceted role of sphingolipids
in inflammation.
Dysregulated formation of several sphingolipids includ-
ing S1P and ceramide has been implicated in inflammatory
bowel disease (IBD). L. Abdel Hadi et al. describe sphin-
golipid metabolism and signaling in IBD and discuss the
potential of sphingolipid-targeted molecules as therapeutic
strategies for this disease.
Metabolic disease, such as obesity and type 2 diabetes, is
emerging as a major health crisis in many countries. High fat
diet is a primary contributing factor for obesity and its related
diseases. S. Choi and A. J. Snider review the evidence for
sphingolipidmetabolism and pathobiology inmodels of high
fat diet.
Glycosphingolipids cluster with sphingomyelin and cho-
lesterol in plasma membranes, forming lipid microdomains
(lipid rafts) considered as platforms for signal transduc-
tion. K. Iwabuchi et al. review the evidence for biological
significance of lactosylceramide-enriched microdomains in
immunological and inflammatory responses of neutrophils.
They also overview the significance of ceramide species and
its metabolites in biological functions. A. M. Bryan et al.
discuss the findings pointing to the importance of sphin-
golipids in immune responses of macrophages and neu-
trophils to fungal infections. R. Ghidoni et al. review roles of
sphingolipid in the pathobiology of lung inflammation.
Three research articles discuss novel findings for S1P and
its receptors. E. Moon et al. discover an involvement of S1P
in stroke damage in initial and recurrent stroke models.
A. Chumanevich et al. reveal that S1P/S1P receptor 2 axis pro-
motes mast cell angiogenic potential. C. Zhao et al. demon-
strate that the sphingolipid pathway controlling S1P levels is
dysregulated in rheumatoid arthritis synovial fibroblasts. In
addition, M. Aoki et al. and S. Mahajan-Thakur et al. review
the evidence pointing to roles of S1P and its receptors in
immune system and blood coagulation system.
This special issue discusses the topics associated with
sphingolipid metabolism and pathobiology in inflammation.
The articles in this special issue not only provide novel
Hindawi Publishing Corporation
Mediators of Inﬂammation
Volume 2016, Article ID 7602526, 2 pages
http://dx.doi.org/10.1155/2016/7602526
2 Mediators of Inflammation
findings in sphingolipid pathobiology, but also discuss the
evidence collected from a large number of research arti-
cles, giving insight into drug discovery for inflammation-
associated diseases.
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